Form 4: Alzamend Neuro Director William B. Horne Acquires Additional Shares

Director William B. Horne purchased 5,000 shares of Alzamend Neuro, Inc. common stock at an average price of $0.9783 on March 20, 2025.

Summary

• On March 20, 2025, William B. Horne, a director of Alzamend Neuro, Inc., acquired 5,000 shares of common stock.
• The shares were purchased in open market transactions at a volume weighted average price of $0.9783 per share.
• The price range for the purchases on that day was between $0.974 and $0.9799 per share.
• Following the transaction, Horne directly owns 26,666 shares of Alzamend Neuro, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. An insider purchase can signal confidence, but the amount is relatively small.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This is a standard disclosure of insider trading activity. It is common for directors and officers of publicly traded companies to buy and sell shares of their company's stock. These transactions are closely monitored by regulators and investors for insights into management's view of the company's prospects.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholders as it signals confidence from a company director.

Key Dates

Keywords

Alzamend Neuro, ALZN, William B. Horne, insider trading, Form 4, stock purchase, director, common stock